SIRION BIOTECH

To optimize adeno-associated vectors (AAV) for gene therapy applications we offer capsid optimization, therapeutic expression cassette optimization, and manufacturing technologies. SIRION Biotech supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, SIRION Biotech has you covered. Platform manufacturing process (USP& DSP) for R&D and preclinical vectors. More than 15 years of viral vector development and production experience. Comprehensive consultation and project management by viral vector experts. CDMO network for smooth transfer of processes to GMP manufacturing. Impact of CD19-CAR inclusion into the lentiviral particle on LV manufacturing.